With 30% of COPD cases misdiagnosed, experts call for improved diagnostic strategies, better disease classification, and ...

SGLT2 inhibitors and GLP-1RAs yielded lower risks for COPD exacerbation than DPP-4 inhibitors among patients with type 2 diabetes.

The risk for moderate or severe COPD exacerbation was lower among those treated with SGLT-2is and with GLP-1 RAs versus DPP-4is.

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased ...

Atrial functional mitral regurgitation (AFMR) is a common type of MR linked to high rates of heart failure, highlighting the need to understand its prognostic factors. Tricuspid regurgitation (TR) is ...

Medics pointed out that dehydration can thicken respiratory secretions, making it more challenging for individuals with respiratory diseases to clear their airways, potentially exacerbating symptoms ...

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased chest muscle loss, according to a new study.

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

New Brunswick Pharmacists' Association says province will not fund expansion of a pilot project for chronic diseases, Strep A ...

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...